NasdaqCM - Delayed Quote USD
Kazia Therapeutics Limited (KZIA)
9.30
-0.49
(-5.01%)
At close: June 13 at 4:00:02 PM EDT
9.40
+0.10
+(1.08%)
After hours: June 13 at 7:59:28 PM EDT
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Cash Flows from Used in Operating Activities Direct
-22,762.66
--
--
--
--
Operating Cash Flow
-9,581
-9,581
-15,156
-22,762
-9,111
Investing Cash Flow
0
0
0
-2,365
0
Financing Cash Flow
5,985
5,985
12,972
3,726
28,109
End Cash Position
1,657
1,657
5,241
7,361
27,587
Issuance of Capital Stock
5,580
5,580
12,972
3,726
28,109
Issuance of Debt
776
776
0
0
--
Repayment of Debt
-371
-371
0
0
--
Free Cash Flow
-9,581
-9,581
-15,156
-22,762
-9,111
6/30/2021 - 1/6/1999
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EVGN Evogene Ltd.
1.3800
-9.21%
NCNA NuCana plc
0.1149
-24.41%
WINT Windtree Therapeutics, Inc.
0.5920
-1.99%
CARM Carisma Therapeutics, Inc.
0.4516
-17.62%
VXRT Vaxart, Inc.
0.7020
+30.73%
CTXR Citius Pharmaceuticals, Inc.
0.8746
-4.93%
LIMN Liminatus Pharma, Inc.
14.42
-29.00%
SNPX Synaptogenix, Inc.
3.7100
-23.66%
PHAT Phathom Pharmaceuticals, Inc.
10.64
+6.08%
CVAC CureVac N.V.
5.57
-0.54%